Evidence map›Paper›PMID 26079509›Full record

ArticlePloS one2015

Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoE(null) Mice.

Irina M Velsko, Sasanka S Chukkapalli, Mercedes F Rivera-Kweh, Hao Chen, Donghang Zheng, Indraneel Bhattacharyya, Pandu R Gangula, Alexandra R Lucas, Lakshmyya Kesavalu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 54 citations in OpenAlex.

  1. IsGut microbes · 2026
    Review
  2. Article
  3. Review
  4. The Role ofBiomedicines · 2026
    Review
  5. Review
  6. MedComm · 2025
    Review
  7. Cancers · 2025
    Review
  8. Article
  9. Review
  10. Oral microbiota in cardiovascular health and disease.Frontiers in cellular and infection microbiology · 2025
    Review
  11. Article
  12. Investigation of the relationship betweenFrontiers in microbiology · 2025
    Article
  13. Article
  14. Review
  15. Regulatory effects of oral microbe on intestinal microbiota and the illness.Frontiers in cellular and infection microbiology · 2023
    Review
  16. Exploring the interplay betweenFrontiers in microbiology · 2023
    Article
  17. Journal of oral microbiology · 2023
    Review
  18. OralBiomedicines · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Irina M VelskoDepartment of Periodontology, College of Dentistry, University of Florida, Gainesville, Florida, United States of America.
Sasanka S ChukkapalliDepartment of Periodontology, College of Dentistry, University of Florida, Gainesville, Florida, United States of America.
Mercedes F Rivera-KwehDepartment of Periodontology, College of Dentistry, University of Florida, Gainesville, Florida, United States of America.
Hao ChenCardiovascular Medicine and Molecular Genetics & Microbiology, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Donghang ZhengCardiovascular Medicine and Molecular Genetics & Microbiology, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Indraneel BhattacharyyaOral Diagnostic Sciences, College of Dentistry, University of Florida, Gainesville, Florida, United States of America.
Pandu R GangulaDepartment of Oral Biology and Research, CWHR Meharry Medical College, Nashville, Tennessee, United States of America; Department of Physiology, CWHR Meharry Medical College, Nashville, Tennessee, United States of America.
Alexandra R LucasCardiovascular Medicine and Molecular Genetics & Microbiology, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Lakshmyya KesavaluDepartment of Periodontology, College of Dentistry, University of Florida, Gainesville, Florida, United States of America; Department of Oral Biology, College of Dentistry, University of Florida, Gainesville, Florida, United States of America.
University of Florida · USMeharry Medical College · US

Funding

Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54RR026140 · NCRR · MEHARRY MEDICAL COLLEGE · PI GOODWIN, JEFFREY SHAWN · 2009 to 2011
$12.9M
Periodontal Pathogens and Cardiovascular DiseaseR01DE020820 · NIDCR · UNIVERSITY OF FLORIDA · PI LAKSHMYYA, KESAVALU NAIDU · 2011 to 2015
$1.8M
NCRR NIH HHS 1U54RR026140-01NCRR NIH HHS U54 RR026140NIDCR NIH HHS R01 DE020820NIDCR NIH HHS R01DE020820NIMHD NIH HHS U54 MD007593
6 · The paper itself

Abstract

The American Heart Association supports an association between periodontal disease (PD) and atherosclerotic vascular disease (ASVD) but does not as of yet support a causal relationship. Recently, we have shown that major periodontal pathogens Porphyromonas gingivalis and Treponema denticola are causally associated with acceleration of aortic atherosclerosis in ApoEnull hyperlipidemic mice. The aim of this study was to determine if oral infection with another significant periodontal pathogen Fusobacterium nucleatum can accelerate aortic inflammation and atherosclerosis in the aortic artery of ApoEnull mice. ApoEnull mice (n = 23) were orally infected with F. nucleatum ATCC 49256 and euthanized at 12 and 24 weeks. Periodontal disease assessments including F. nucleatum oral colonization, gingival inflammation, immune response, intrabony defects, and alveolar bone resorption were evaluated. Systemic organs were evaluated for infection, aortic sections were examined for atherosclerosis, and inflammatory markers were measured. Chronic oral infection established F. nucleatum colonization in the oral cavity, induced significant humoral IgG (P=0.0001) and IgM (P=0.001) antibody response (12 and 24 weeks), and resulted in significant (P=0.0001) alveolar bone resorption and intrabony defects. F. nucleatum genomic DNA was detected in systemic organs (heart, aorta, liver, kidney, lung) indicating bacteremia. Aortic atherosclerotic plaque area was measured and showed a local inflammatory infiltrate revealed the presence of F4/80+ macrophages and CD3+ T cells. Vascular inflammation was detected by enhanced systemic cytokines (CD30L, IL-4, IL-12), oxidized LDL and serum amyloid A, as well as altered serum lipid profile (cholesterol, triglycerides, chylomicrons, VLDL, LDL, HDL), in infected mice and altered aortic gene expression in infected mice. Despite evidence for systemic infection in several organs and modulation of known atherosclerosis risk factors, aortic atherosclerotic lesions were significantly reduced after F. nucleatum infection suggesting a potential protective function for this member of the oral microbiota.

Indexed as

Gene DeletionAnimalsAortaApolipoproteins EBiomarkersCytokinesDisease ProgressionFusobacterium nucleatumGingival DiseasesImmunity, HumoralInflammationMaleMiceMouthPlaque, AtheroscleroticRisk FactorsApolipoproteins EBiomarkersCytokines

Identifiers

PMID26079509
PMCPMC4469693
OpenAlexW594443940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.